19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Alzheimers Disease and other Cognitive Disorders
Resources
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
Can Alzheimer's Be Spread? Mouse Study Hints It's PossibleDoctors' Office Dementia Tests Are Often Wrong: StudyAlzheimer's Vaccine Shows Promise in MiceKey Strategies When Caring for a Loved One With DementiaFor Down Syndrome Adults, Death and Dementia Often Come TogetherAHA: What's the Blood Pressure Connection to Alzheimer's Disease?Could Diabetes Drugs Help Curb Alzheimer's?Hard Arteries Hard on the Aging Brain?Widely Used Antipsychotics May Not Ease Delirium in ICUCould Herpes Virus Help Cause Alzheimer's?Map of Mouse Hippocampus Could Be Weapon Against Alzheimer'sHealth Tip: 10 Signs of Alzheimer'sA-Fib Tied to Higher Odds for DementiaAlzheimer's Gene Tied to 'Chemo Brain' in Breast Cancer SurvivorsDiabetes, Dementia Can Be Deadly CombinationWhat's the Dollar Cost of Caring for a Loved One With Alzheimer's?Exercise May Delay Rare Form of Alzheimer'sAHA: Stiffening of Blood Vessels May Point to Dementia RiskU.S. Alzheimer's Cases to Nearly Triple by 2060Daytime Drowsiness a Sign of Alzheimer's?Exercise May Boost Brain Power in Alzheimer's, Mouse Study SuggestsSeverity of Alzheimer's Can Vary by SeasonHealth Tip: Help Kids Understand Alzheimer'sWith Stroke Comes Higher Dementia Risk: StudyEyes Could Be Window to Predicting Alzheimer'sDialysis Linked to Dementia in SeniorsWhen Head Injuries Make Life Too Hard, Suicide Risk May RiseMore Alzheimer's Gene Links FoundEye Disease Link to Alzheimer's SeenHow Severe Brain Injuries Might Trigger DementiaAlzheimer's Drug Trial Offers New Hope, But Uncertainty, TooGet Dizzy Upon Standing? It Could Be Sign of Dementia RiskSleeping Pills May Be Poor Choice for Dementia PatientsVirtual Reality as a Window Into DementiaThe Right Lighting Can Calm Alzheimer's PatientsCould Pot-Linked Drug Help Ease Agitation in Alzheimer's?Many Americans With Dementia Don't Know They Have It: StudyHaving More Kids Tied to Lower Odds of Alzheimer's in WomenWhy Alzheimer's May Be Tougher to Spot in WomenHow Common Is Dementia Among LGBT Seniors?Life Is Short After Dementia Diagnosis, No Matter Your AgeDoes a Woman's Childbearing History Affect Her Alzheimer's Risk?Health Tip: What's the Difference Between Delirium and Dementia?Obesity Adds to Burden of Traumatic Brain InjuryCould Aspirin Help Keep Alzheimer's Away?Scientists Spot Gene Linking Down Syndrome, Early Alzheimer'sRobots May Soon Join Ranks of Alzheimer's CaregiversCould Herpes Virus Play a Role in Alzheimer's?Health Tip: Living With Dementia"Markers" of Alzheimers Do Not Doom You to Dementia
Questions and AnswersVideosLinksBook Reviews
Related Topics

Aging & Geriatrics
Memory Problems
Elder Care

Alzheimer's Gene Tied to 'Chemo Brain' in Breast Cancer Survivors

HealthDay News
by By Dennis ThompsonHealthDay Reporter
Updated: Oct 3rd 2018

new article illustration

WEDNESDAY, Oct. 3, 2018 (HealthDay News) -- Many older breast cancer patients might worry that they will be struck by "chemo brain" after their treatments, but a new study suggests that only those who carry a gene linked to Alzheimer's face that risk.

Researchers found that breast cancer survivors carrying the APOE4 gene who underwent chemotherapy were more likely to experience long-term impairment in brain function.

But the study did not prove that the gene caused the cognitive (thinking) problems known as chemo brain. And the declines observed were small, the study authors added.

"It was only a small group who had cognitive problems after chemotherapy treatment, and those women were distinct in having that APOE4 gene," said lead researcher Dr. Jeanne Mandelblatt. She is a professor of oncology at Georgetown Lombardi Comprehensive Cancer Center, in Washington, D.C.

These results are good news for the large majority of breast cancer survivors. Most women who received chemotherapy or hormone therapy didn't experience long-term thinking or memory declines related to either their cancer or their treatment, the findings showed.

"Our study suggests that, for most older breast cancer patients, chemotherapy and hormonal treatments do not have major adverse effects on cognitive function, at least as measured by our current tests," Mandelblatt said.

Experts have long been concerned that older people might be at increased risk for thinking and memory problems related to cancer treatment, Mandelblatt said.

Aging is already related to dementia and Alzheimer's disease, she noted, and seniors also face a number of other health problems that affect their ability to think.

For the study, researchers recruited 344 breast cancer patients between the ages of 60 and 98. These women were compared with 347 healthy women of similar ages, to see whether breast cancer or its treatments spurred any sort of intellectual decline.

Both groups of women were given a battery of 13 cognitive tests at the beginning of the study, before cancer patients received any treatment. They were re-tested one and two years later.

Tests showed that women treated with hormone therapy suffered no long-term cognitive problems, whether or not they carried the APOE4 gene.

But breast cancer patients with the APOE4 gene did experience a notable decline in thinking and memory if they received chemotherapy, the researchers reported.

"The APOE4 gene is a very strong genetic risk factor for Alzheimer's disease," Mandelblatt said. "There's probably some interaction between chemotherapy and something this gene controls, but we're very careful to say this finding needs to be replicated. We also need to take this into the laboratory so we can understand better the mechanisms and pathways."

Only 20 percent to 25 percent of people are APOE4-positive, Mandelblatt said, and fewer than 30 percent of older breast cancer patients receive chemotherapy.

And she emphasized that the mental declines observed were not large.

"The types of cognitive changes we observed even in this group who were at genetic risk, these changes were reasonably mild and not of the magnitude you see in Alzheimer's disease," Mandelblatt said. "We don't want women to worry that they're going to have severe memory problems. These were mild declines in cognitive abilities."

So, it's too soon to include the APOE4 gene in discussions about breast cancer treatment, Mandelblatt stressed.

"It needs more research before we can make a recommendation like that," Mandelblatt concluded. "The primary consideration for women in choosing their treatment is to survive their cancer. If their cancer is more advanced, they're going to want to choose the most aggressive treatment so they survive their disease."

One cancer expert agreed.

The current trend is to use chemotherapy less often in treating breast cancer patients, given recent findings that show it's often not needed, said Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society.

"On the other side of the equation, women whose breast cancer has recurred may require chemotherapy, and there may not be an option to avoid it even with the presence of this gene," Lichtenfeld said.

More research and discussion are needed before treatment guidelines are changed to take into account the APOE4 gene, Lichtenfeld said.

"It's very rare we immediately change course on what we do," Lichtenfeld said. "We certainly need perhaps more research and certainly more discussion before routinely testing women for the presence of that gene."

The study was published Oct. 4 in the Journal of Clinical Oncology.

More information

The U.S. National Institute on Aging has more about genetics and Alzheimer's disease.